Skip to main content

Viral Inhibitor

Inventors from Penn State and Yeshiva University have developed novel therapeutic from a nucleotide analog with unique composition-of-matter that can be used to treat flavivirus infections with a unique mechanism of action that makes them capable of treating both DNA and RNA viruses.

-Craig Cameron

Image featuring two professionals shaking hands.

We work together with the Office of Technology Management (OTM) and the Office for Industrial Partnerships (OIP), engaging in assisting inventors in capturing Intellectual Property (IP), and providing academic resources and support to entrepreneurs.